Intelligent Bio Solutions (INBS) Stock Price, News & Analysis

Company Overview

Intelligent Bio Solutions, Inc., through its wholly owned subsidiary, is focused on the design, development and marketing of rapid, real-time detection and identification systems for foodborne and environmental pathogens. The company’s flagship product, the RAPID-B System, integrates patented biosensor and fluorescence technologies to detect viable microorganisms in a fraction of the time required by traditional culture-based testing methods. This approach enables food processors, beverage producers, environmental testing laboratories and homeland security agencies to identify contaminants such as Escherichia coli O157:H7, Salmonella spp. and Listeria monocytogenes in under one hour.

In addition to the RAPID-B instrument, Intelligent Bio Solutions offers a portfolio of assay kits and consumables tailored for specific pathogen targets and sample matrices. These test kits have undergone evaluations by regulatory bodies including the U.S. Food and Drug Administration and the U.S. Department of Agriculture, and are used in quality control, process verification and regulatory compliance workflows. By shortening time-to-result and reducing labor and material costs, the company’s rapid testing solutions help organizations respond more quickly to contamination events and improve overall product safety.

Founded in 1998 and headquartered in Houston, Texas, Intelligent Bio Solutions serves a global customer base through direct sales and a network of distribution partners. The company’s leadership team combines expertise in biosensor engineering, microbiology and regulatory affairs to drive ongoing product innovation and market development. Looking ahead, Intelligent Bio Solutions seeks to expand its detection capabilities, broaden its application scope and enter new markets such as clinical diagnostics and pharmaceutical contamination monitoring.

Key Stats

• Today's Range: $2.35 to $2.43
• 50-Day Range: $2.35 to $4.50
• 52-Week Range: $2.29 to $24.90
• Volume: 17,917 shs
• Average Volume: 499,031 shs
• Market Capitalization: $4.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Intelligent Bio Solutions Stock Analysis - MarketRank™

Intelligent Bio Solutions scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Intelligent Bio Solutions has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Intelligent Bio Solutions has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Intelligent Bio Solutions is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Intelligent Bio Solutions is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Intelligent Bio Solutions has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.37% of the float of Intelligent Bio Solutions has been sold short.

Short Interest Ratio / Days to Cover

Intelligent Bio Solutions has a short interest ratio ("days to cover") of 0.21, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Intelligent Bio Solutions has recently decreased by 39.28%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Intelligent Bio Solutions does not currently pay a dividend.

Dividend Growth

Intelligent Bio Solutions does not have a long track record of dividend growth.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: N/A

News Sentiment

Intelligent Bio Solutions has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Intelligent Bio Solutions this week, compared to 4 articles on an average week.

Search Interest

4 people have searched for INBS on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.27% of the stock of Intelligent Bio Solutions is held by insiders.

Percentage Held by Institutions

32.97% of the stock of Intelligent Bio Solutions is held by institutions.

INBS Stock Analysis - Frequently Asked Questions

How have INBS shares performed this year?

Intelligent Bio Solutions' stock was trading at $9.53 at the beginning of 2026. Since then, INBS stock has decreased by 74.7% and is now trading at $2.4150.

How were Intelligent Bio Solutions' earnings last quarter?

Intelligent Bio Solutions Inc. (NASDAQ:INBS) posted its quarterly earnings results on Thursday, February, 12th. The company reported ($2.82) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by $3.22. The business earned $0.90 million during the quarter, compared to the consensus estimate of $5.50 million. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 200.68% and a negative net margin of 315.33%.

When did Intelligent Bio Solutions' stock split?

Shares of Intelligent Bio Solutions reverse split on the morning of Monday, January 29th 2024.The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

When did Intelligent Bio Solutions IPO?

Intelligent Bio Solutions (INBS) raised $22 million in an initial public offering on Wednesday, December 23rd 2020. The company issued 1,270,589 shares at a price of $16.00-$18.00 per share.

How do I buy shares of Intelligent Bio Solutions?

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Intelligent Bio Solutions own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include SoFi Technologies (SOFI), Plug Power (PLUG), Allarity Therapeutics (ALLR), Adial Pharmaceuticals (ADIL), AMC Entertainment (AMC), ARMOUR Residential REIT (ARR) and BIOLASE (BIOL).

Company Calendar

• Last Earnings: 2/12/2026
• Today: 5/06/2026
• Next Earnings (Estimated): 5/12/2026
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:INBS
• Previous Symbol: NASDAQ:GBS
• CIK: 1725430
• Web: gbs.inc
• Phone: 646-828-8258
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($14.82)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 0.68
• P/E Growth: N/A
• Net Income: -$10.57 million
• Net Margins: -315.33%
• Pretax Margin: -316.44%
• Return on Equity: -200.68%
• Return on Assets: -97.31%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.37
• Quick Ratio: 2.26

Sales & Book Value

• Annual Sales: $3.05 million
• Price / Sales: 1.57
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.07 per share
• Price / Book: 0.59

Miscellaneous

• Outstanding Shares: 2,000,000
• Free Float: 1,976,000
• Market Cap: $4.79 million
• Optionable: Not Optionable
• Beta: 4.24